Author

Y. Kaneko

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Cell Biology· 1 Ecology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:multiple species· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Saito· 2 shared A. Hoshino· 1 shared A. K. Scharf· 1 shared A. Katagiri· 1 shared A. Ohkawa· 1 shared A. Roulin· 1 shared A. Shibanai· 1 shared A. Taruno· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Saito

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Conserved use of the sodium/bile acid cotransporter (NTCP) as an entry receptor by hepatitis B virus and domestic cat hepadnavirus

M. Shofa, A. Ohkawa, Y. Kaneko, A. Saito

This study identifies NTCP as the entry receptor for domestic cat hepadnavirus, showing similarity to HBV and suggesting potential for cross-species transmission.

bioRxiv · Feb 4, 2023Microbiology

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.

M. Takeshita, H. Fukuyama, K. Kamada, T. Matsumoto, C. Makino-Okamura, T. Uchikubo-Kamo, Y. Tomabechi, K. Hanada, S. Moriyama, Y. Takahashi, H. Ishigaki, M. Nakayama, C. T. Nguyen, Y. Kitagawa, Y. Itoh, , T. Takeuchi

The paper develops Fc-modified SARS-CoV-2 neutralizing antibodies effective against variants, showing reduced viral titers and lung damage in animal models.

bioRxiv · Jun 21, 2022 · PreprintMicrobiology

Liver lipophagy ameliorates nonalcoholic steatohepatitis through lysosomal lipid exocytosis

Y. Minami, A. Hoshino, Y. Higuchi, M. Hamaguchi, Y. Kaneko, Y. Kirita, S. Taminishi, A. Taruno, M. Fukui, A. Zoltan, S. Matoba

This study identifies lipophagy as a therapeutic approach to prevent NASH progression by promoting lysosomal lipid exocytosis and reducing intracellular fatty acid accumulation.

bioRxiv · Feb 22, 2022 · PreprintCell Biology

Identification of domestic cat hepadnavirus from a cat blood sample in Japan

K. Takahashi, Y. Kaneko, A. Shibanai, S. Yamamoto, A. Katagiri, T. Osuga, Y. Inoue, K. Kuroda, M. Tanabe, T. Okabayashi, K. Naganobu, I. Minobe, A. Saito

The study identifies a domestic cat hepadnavirus infection in a Japanese cat, showing genetic differences from global strains.

bioRxiv · Jan 9, 2022Microbiology

A comprehensive framework for handling location error in animal tracking data

C. H. Fleming, J. Drescher-Lehman, M. J. Noonan, T. S. B. Akre, D. J. Brown, M. M. Cochrane, N. Dejid, V. DeNicola, C. S. DePerno, J. N. Dunlop, N. P. Gould, A.-L. Harrison, J. Hollins, H. Ishii, Y. Kaneko, , J. M. Calabrese

This paper introduces a framework for handling location error in animal tracking data, showing that error-model selection improves analysis accuracy across various tracking devices and species.

bioRxiv · Jun 12, 2020 · PreprintEcology